The major challenge in treating methamphetamine addicts is the maintenance of a drug free-
state since they experience negative emotional symptoms during abstinence, which may …

Recently, oxytocin (OXT) has been investigated for its potential therapeutic role in addiction.
OXT has been found to diminish various drug-seeking and drug-induced behaviors …

The neuropeptide oxytocin (OT), given acutely, reduces self‐administration of the
psychostimulant drug methamphetamine (METH). Additionally, chronic OT administration to …

There is mounting evidence that the neuropeptide oxytocin is a possible candidate for the
treatment of drug addiction. Oxytocin was shown to reduce methamphetamine self …

Drug abuse is a worldwide problem that leads to negative physical, mental, and economic
consequences. Although pharmacological strategies for drug addiction management have …

Methamphetamine addiction is characterized by compulsive binges of drug intake despite
adverse life consequences. A model of methamphetamine self-administration that includes …

Behavioral and neuroplastic changes occurring in the development of addiction parallel
those that occur in social bonding. This has led to speculation that drugs of abuse co-opt …

Background: The incentive sensitisation theory of addiction posits that drug-associated
stimuli become imbued with incentive motivational properties, driving pathological drug …

Early studies attempting to disentangle the network complexity of the brain exploited the
accessibility of sensory receptive fields to reveal circuits made up of synapses connected …

Patients and psychotherapists often exhibit behavioral, psychological, and physiological
similarity. Here, we test whether oxytocin—a neuropeptide that can enhance expressivity …